Results 61 to 70 of about 7,162 (211)

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

open access: yesAnnals of Clinical and Translational Neurology, Volume 13, Issue 4, Page 688-699, April 2026.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer   +14 more
wiley   +1 more source

Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring

open access: yes
Annals of Clinical and Translational Neurology, Volume 13, Issue 6, Page 1301-1302, June 2026.
Francesco Saccà, Ryan Pelto
wiley   +1 more source

The Mitochondrial Guardian α‐Amyrin Mitigates Alzheimer's Disease Pathology via Modulation of the DLK‐SARM1‐ULK1 Axis

open access: yesAdvanced Science, Volume 13, Issue 24, 27 April 2026.
Dietary habits play a key role in chronic diseases, and higher annual consumption of fruit and vegetable may lower risk of dementia. Artificial intelligence predicts the lipid‐like compound α‐Amyrin (αA) from plants with edible peels as a drug candidate against Alzheimer's disease.
Shu‐Qin Cao   +36 more
wiley   +1 more source

Living with Atypical Hemolytic Uremic Syndrome in the Netherlands: Patient and Family Perspective

open access: yesKidney International Reports
Introduction: Atypical hemolytic uremic syndrome (aHUS) poses a significant health challenge due to its rarity and severity within the spectrum of thrombotic microangiopathy. Despite efforts to optimize and personalize health care for patients with aHUS,
Romy N. Bouwmeester   +7 more
doaj   +1 more source

Optimization of Phenolic and Flavonoid Extraction From Bee Bread Using Response Surface Methodology and Central Composite Design, and Evaluation of Antimicrobial Activity

open access: yesFood Science &Nutrition, Volume 14, Issue 4, April 2026.
This study successfully optimized the extraction parameters for Turkish bee bread using Response Surface Methodology (RSM) with a Central Composite Design (CCD). Under optimized conditions (30°C, 40 mL/g ratio, 66.7% ethanol, 20 h), the recovery of total phenolics (26.86 mg GAE/g) and flavonoids was maximized.
Nilay Keyvan   +6 more
wiley   +1 more source

Real-world use of complement inhibitors for haemolytic uraemic syndrome: an analysis of the European Rare Kidney Disease Registry cohortResearch in context

open access: yesEClinicalMedicine
Summary: Background: Although terminal complement inhibitors transformed the prognosis of atypical haemolytic uraemic syndrome (aHUS) from dismal to favourable, treatment approaches vary due to the intermittent disease nature and high costs ...
Aleksandra Vujović   +173 more
doaj   +1 more source

Atypical Hemolytic Uremic Syndrome post Kidney Transplantation: Two Case Reports and Review of the Literature

open access: yesFrontiers in Medicine, 2014
Atypical hemolytic uremic syndrome (aHUS) is a rare disorder characterized by over-activation and dysregulation of the alternative complement pathway. Its estimated prevalence is 1-2 per million. The disease is characterized by thrombotic microangiopathy,
Sami eAlasfar, Nada eAlachkar
doaj   +1 more source

Antimicrobial‐Resistance Genetic Markers Among Multidrug‐Resistant Enterobacteriaceae and Acinetobacter spp. From Vegetable Market Chains in Ethiopia

open access: yesFood Science &Nutrition, Volume 14, Issue 4, April 2026.
Schematic overview of the study workflow explaining isolation of lactose‐fermenting Gram‐negative bacteria from farms and supermarkets, antimicrobial susceptibility testing, detection of resistance genes by PCR, and ERIC‐PCR to evaluate genetic diversity and relatedness among isolates.
Hemen Tesfaye   +9 more
wiley   +1 more source

atypisches hämolytisch urämisches Sydrom (aHUS)

open access: yes, 2020
ZusammenfassungDas Kapitel 10 beinhaltet eine Zusammenstellung der am Universitätsklinikum Freiburg verwendeten Tumortherapie- und ggf. Studien-Protokolle der Entität Atypisches hämolytisch-urämisches Syndrom (aHUS). Der Kapitelinhalt orientiert sich an aktuellen Leitlinien und Therapieempfehlungen und spiegelt detailliert die Therapieabläufe inkl ...
Monika Engelhardt   +2 more
openaire   +1 more source

The Eco-Design Directive ErP for AHUs

open access: yes, 2017
The European ErP-Directive 2009/125/EG (Energy-related-Products-Directive), also called the Eco-Design Directive, defines the minimal requirements for energy-related products.
Cătălin George Popovici
core   +1 more source

Home - About - Disclaimer - Privacy